Skip to content

Clinical trials

Phase 1/2 Gaucher Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gaucher Disease Phase: Phase 1/2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20122
20191
20201
20211
20222
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed2
Not yet recruiting2
Recruiting1
Suspended1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Prevail Therapeutics3
Shire2
AVROBIO1
CANbridge (Suzhou) Bio-pharma Co., Ltd.1
Exsar Corporation1
Lingyi Biotech Co., Ltd.1
Shanghai Vitalgen BioPharma Co., Ltd.1
Shenzhen Geno-Immune Medical Institute1
Spur Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gaucher Disease12
Anemia1
Neuroblastoma1
Parkinson Disease1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.